top of page

First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases

Verwaerde P, Estrella C, Burlet S, Barrier M, Marotte AA, Clincke G.

J Alzheimers Dis. 2024;98(2):715-727. doi: 10.3233/JAD-220883.

2024

PMID

38427472

PSP

First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases
bottom of page